Health Care/Hospital
Healgen Scientific Spotlights the Rapid Check® COVID-19/Flu A&B Antigen Test to Help Families Stay Prepared for the Respiratory Virus Season
HOUSTON, Nov. 26, 2025 /PRNewswire/ -- As the holiday season approaches, gatherings among family and friends are expected to increase the risk of respiratory virus transmission, including COVID-19 and influenza. In response, Healgen® Scientific highlights the Rapid Check® COVID-19/Flu A&B Antigen ...
2025-11-27 00:00
771
China Cycle 2026: Building An Innovation Driven, Intelligence-led Future
SHANGHAI, Nov. 26, 2025 /PRNewswire/ -- The 34th China International Bicycle Fair (China Cycle 2026) is expected to unveil the grand exhibition fromMay 5 to 8, 2026 at the Shanghai New International Expo Center (SNIEC), themed "Innovation-Driven, Intelligence-Led Future." Building on three decade...
2025-11-26 22:10
630
Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA® (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal
* Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless of disease location, consistent across ileum-dominant and colon-dominant Crohn's disease (CD) * Findings support the therapeutic potential of ZYMFENTRA in addressing ...
2025-11-26 14:48
1422
Vital Signs highlights how researchers are "cracking the code on the genome" to harness the biomedical superpowers of hibernating animals
HONG KONG, Nov. 26, 2025 /PRNewswire/ -- In a groundbreaking new episode, CNN's long-running seriesVital Signs delves into the cutting-edge science of hibernation, revealing how the secrets of the animal kingdom could unlock revolutionary advancements in human health, from fighting cancer and hea...
2025-11-26 14:44
825
Renalys Pharma Announces Positive Topline Results from Phase III Study of Sparsentan in Japanese Patients with IgA Nephropathy
– In a Phase 3 clinical study evaluating the efficacy and safety of sparsentan in Japanese patients with IgA nephropathy (N=35), the percent change from baseline in the 24-hour urine protein-to-creatinine ratio at Week 36, which was the study's primary endpoint, was -58.54%. Sparsentan was well-t...
2025-11-26 14:00
805
Korea Innovation Foundation selects 2 Innovative bio health companies, LEEBIO, and Airlab for Global Technology Commercialization Support Program (North America)
DAEJEON, South Korea, Nov. 26, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support Program (North America), announces that 2 innovative companies, LEEBIO, and Airlab are chosen for the support program. This initia...
2025-11-26 13:45
771
Chiron Medical Advances Women's Health with Expanded "1:1 Breast Health Empowerment Charity Campaign"
300 Free 3D Mammogram Screenings Donated to Community Women, Championing Self-Care and Compassionate Support HONG KONG, Nov. 26, 2025 /PRNewswire/ -- Building on its commitment to accessible healthcare, Chiron Medical Group (Referred as "Chiron") launched the "1:1 Breast Health Empowerment Chari...
2025-11-26 13:03
697
The Unseen Itch: Over Half of Singaporeans With Eczema Struggle With Sleep Loss, Shame and Social Withdrawal Due to Itch
A recently concluded survey by Medical Channel Asia sheds light on the
debilitating effects of constant itch caused by eczema.
SINGAPORE, Nov. 25, 2025 /PRNewswire/ -- A new ground-up survey "The Unseen
Itch: How Eczema Disrupts Daily Life inSingapore" by Medical Channel Asia
2025-11-26 10:33
1028
Precious Hospital Sdn. Bhd. to Launch Cancer Centre and Hospital in Johor Bahru
First cyclotron outside Klang Valley to anchor Malaysia's advanced cancer care ecosystem KEY-HIGHLIGTHS * RM500 million investment in advanced cancer care infrastructure * State-of-the-art diagnostic and treatment facilities, including a nuclear medicine centre * First cyclotron outside th...
2025-11-26 10:00
885
Triple the Probiotics, Triple the Relief: Life-Space Launches Triple Strength Probiotics in Southeast Asia
Engineered by Australia's leading probiotics expert, this high CFU probiotic delivers the ultimate gut defense, helping to reduce gut transit time by up to 18 hours. SINGAPORE, Nov. 26, 2025 /PRNewswire/ -- Life-Space, Australia's No.1 probiotic brand, proudly unveilsTriple Strength Probiotics, ...
2025-11-26 09:57
935
Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuznue® Commercialization in Latin America
SINGAPORE, Nov. 26, 2025 /PRNewswire/ -- Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered inBuenos Aires, Argentina, with decades of experience in ...
2025-11-26 09:06
1222
Professor Chan Heum Park's Team at Hallym University Chuncheon Sacred Heart Hospital Sends Their Self-Developed "BioCabinet" to Space Aboard Nuri Rocket
SEOUL, South Korea, Nov. 26, 2025 /PRNewswire/ -- Chan Hum Park, M.D., Ph.D., Professor of Otolaryngology at Hallym University Chuncheon Sacred Heart Hospital and Director of the Nano-Bio Regenerative Medical Institute at Hallym University, leads the research team whose space biology payload, Bio...
2025-11-26 07:30
932
Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition
The acquisition of Enci Therapeutics will advance Innova Therapeutics' lead program, IVT-8086, a humanized monoclonal antibody targeting SFRP2 which is expressed in most solid and hematological cancers. IVT-8086 is the only cancer therapeutic that targets multiple cell types associated with canc...
2025-11-25 23:06
625
BON Announced Next-Gen of Tea Pigment Digestive Health Products and Cooperation Agreement of US$26 Million with Beijing Huahai Keyuan
XI'AN, China, Nov. 25, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, today announced a non-exclusive cooperation agreement with Beijing Huahai Keyuan Technology Co...
2025-11-25 22:41
968
Mabwell Announces First-Patient Dosing for Novel CDH17-Targeting ADC 7MW4911
SHANGHAI, Nov. 25, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that the first patient has been dosed in the Phase I/II clinical trial of its independently developed novel CDH17-targeting antibody-drug ...
2025-11-25 22:00
877
Neurophet and The Florey Strengthen Research Collaboration on 'Neurophet AQUA' to Advance Alzheimer's Disease Diagnosis
* Aiming to evaluate the utility of blood-based and other biomarkers for Alzheimer's disease diagnosis and management * Joint research to enhance dementia diagnosis using the brain neurodegeneration imaging software 'Neurophet AQUA' SEOUL, South Korea, Nov. 25, 2025 /PRNewswire/ -- Neurophet ...
2025-11-25 22:00
1286
JUNG KWAN JANG Launches Black Friday & Holiday Promotions and Introduces New Wellness Innovations for U.S. Consumers
* Global wellness brand JUNG KWAN JANG rolls out major Black Friday and holiday-season promotions across the U.S. * New products including EVERYTIME and Hong Sam Won gain momentum on Amazon, Costco, and other major retail channels * Korean Red Ginseng rises worldwide as a leading natural, n...
2025-11-25 21:00
805
Hong Kong to Host International Summit on Heart and Brain Health, Spotlighting AI and Startup Innovations
HONG KONG, Nov. 25, 2025 /PRNewswire/ -- The 2nd International Cerebro-cardiovascular Medical Innovation Summit (ICMIS 2025) will bring together global leaders to discuss cutting-edge research, innovative medical products, and cross-border collaborations to accelerate progress toward advanced ce...
2025-11-25 20:54
839
TCL CSOT Unveils "2025 Eye-Care Technology White Paper", Setting New Benchmarks for Natural-Light Display Standards
SUZHOU, China, Nov. 25, 2025 /PRNewswire/ -- TCL China Star Optoelectronics Technology (TCL CSOT), a global leader in advanced display technologies and a subsidiary of TCL Technology (000100.SZ), in collaboration with the National Engineering Research Center for Ophthalmology & Optometry of Wenzh...
2025-11-25 18:01
1075
Exyte completes Pharmaplan integration: A-to-Z execution in GMP facilities
* Pharmaplan fully integrated into Exyte, unifying biopharma engineering capabilities under one European organization. * Integrated setup drives strong client demand and a record order-intake level in 2025. * End-to-end EPC/EPCM delivery from feasibility to qualified handover across key lif...
2025-11-25 18:00
947
Week's Top Stories
Most Reposted
Tonik raises US$12M Pre-Series C to scale capital-efficient lending in the Philippines
[Picked up by 318 media titles]
2025-12-04 10:15
Hyundai Motor Group and Air Liquide Advance Global Partnership to Accelerate Hydrogen Ecosystem
[Picked up by 310 media titles]
2025-12-04 16:00
Klook takes the lead among international travelers booking paid tours and activities in Japan
[Picked up by 309 media titles]
2025-12-04 13:12
World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 297 media titles]
2025-12-03 09:00
Hyundai Motor Group Fosters Collaboration with Hydrogen Industry Leaders at Hydrogen Council Global CEO Summit
[Picked up by 295 media titles]
2025-12-04 15:00
Most Read
Abu Dhabi signs agreements and explores opportunities to strengthen partnerships with India and Singapore
2025-12-06 09:00
2930
Taipei City's Global Pass: A New Partner Channel for Global Startup Spaces
2025-12-06 01:06
2576
